Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
179K on Tape in 6s
Big trade, $104
12.7M Converted Today
Purple Trade below the BID was the MM completing the Conversion trade.
They pulled the bandaid off , LOL
Converter has to end of year to get it done, so grab some cheap share while you can, 2023 going to look
very different.
Schumer Makes ‘Last Ditch Effort’ To Put Marijuana Banking In Spending Bill
2 hours ago on December 16, 2022
Senate Majority Leader Chuck Schumer (D-NY) is “making a last ditch effort” to put marijuana banking reform in forthcoming omnibus appropriations legislation, a senior Senate Democratic aide told Marijuana Moment on Friday.
With time running short in the lame duck session, there’s been a concerted push to use the spending package as the vehicle for the Secure and Fair Enforcement (SAFE) Banking Act. Lawmakers failed to secure a deal to attach the reform to a must-pass defense bill last week, leaving them with limited legislative options.
There are some GOP senators who’ve expressed support for moving the cannabis banking proposal, either as part of large-scale legislation or as a standalone, but other key players like Senate Minority Leader Mitch McConnell (R-KY) and Sen. John Cornyn (R-TX) represent major obstacles.
Negotiations were partly complicated after a Justice Department memo from earlier this year surfaced in a report, revealing that DOJ had some concerns about possible unintended consequences of enacting SAFE Banking. That prompted several Republican senators to hold a meeting with the department last week.
On Thursday, Democrats shared revised SAFE Banking text with Republicans that “addresses DOJ implementation and money laundering concerns,” the top staffer told Marijuana Moment and other news outlets on Friday. “Democrats have also presented language aimed at addressing the issue of legacy cash.”
We know we are closer to bottom than TOP, LOL
Gets kind of hard trying to push the price to zero, when you generate over $20M in revenue and will be growing rapidly in 2023 and 2024, hey have at it, I like my odds here, still buying!!!
12M shares set the price for 5 Billion Share Float?
That is $12k has set the price for the entire companies 5 Billion share float, LOL
Means nothing at all, no one is selling and no one buying a stare off!!!
Market Cap is $4.1M while Revenue exceeds $20M, LOL
Pink Sheet stocks are impossible to predict and fundamentals are not recognized by trades, it all about the price can they shove it DOWN or will they Take it UP, LOL
How about the pink cannabis stock that had revenue of $1.5M per qtr, and traded at .003 and it ran to over 2 cents, with 17 Billion share outstanding.
The market cap of that company exceeded $750 MILLION, seriously almost $1 BILLION and it is now back to where it all started. So many scams and so little time.
PVSP is a real company with real revenues and real operating business. Is it worth $700 million today? I don't think so. Is it worth more than $4 M today, of course it is and everyone here knows it.
20M of the 35M was the Conversion
Almost no trading really, outside the conversion. MM get on the ASK and short those shares, which are then covered with the Conversion shares before the close at at a lower price than what the BID is, and trade shows up as a "Purple Trade", meaning it occurred outside the BID and ASK.
Almost no real selling or buying for that matter, LOL
Just over 10 Million Converted today!! Almost Done!!
The Purple Tape says 10,150,522 was the number today. Keeping track of the Conversion Shares, Mammoth Corp, is the converter, only had 170M when this started last month, and it will be done soon, end of year is my guess, before the Name change.
Buy em, while you can these cheap share will soon be history!!!!
PVSP Twitter
Pervasip Corp
@PervasipC
·
2h
$PVSP Washington's New Craft brand! New School by Artizen ??????
https://leafmagazines.com/magazines/northwest-leaf/https://twitter.com/PervasipC?
ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
7.5 M shares converted equals 15M volume
40 M total volume flipping around shares to get the conversions done. May be some truth that they want to get these done by end of year, they sure look like they are pushing hard to get it done. Last conversion was only 170M shares so they might just get it done and start 2023 with new company name change and new ticker.
Sundial just got $70M Debt Financing!!
Cannabis starting to get some love from the financing industry!!
Conversions very active this week, get er done Yr end
Big push again, almost ALL trading is MM getting it done before end of year and name change etc.
Death Spiral, LOL Absolutely Untrue
Do you even know what Death spiral convertibles are? We have NONE. All Convertibles have FIXED Share Prices, and the lowest ones are the one we are seeing now, which are at .0001, with other small amounts with Floor prices of .0025 per share, which are underwater for the Converter at these prices, LOL
Heard they may be getting all Convertibles done by year end!!
Our partner KRTL up 76% Big Deal!!
Check it out, we should start moving soon!!!
Biden Signs Marijuana Research Bill,
A Historic First For Federal Cannabis ReformPublished 4 hours ago on December 2, 2022By Kyle Jaeger
President Joe Biden has officially signed a marijuana research bill into law, making history by enacting the first piece of standalone federal cannabis reform legislation in U.S. history.
The bill cleared the House in April and the Senate last month, and a White House spokesperson confirmed to Marijuana Moment that the president intended to sign it. On Friday, he did just that.
The law gives the U.S. attorney general 60 days to either approve a given application or request supplemental information from the marijuana research applicant. It also creates a more efficient pathway for researchers who request larger quantities of cannabis.
The president remains opposed to federal cannabis legalization, but he campaigned on a number of more modest marijuana reforms, including promoting research, decriminalization and rescheduling cannabis under the Controlled Substances Act (CSA).
Biden also issued a mass pardon for Americans who’ve committed federal marijuana possession cases in October and directed an administrative review into cannabis scheduling. The White House recently listed those actions among the “top accomplishments” for the president.
Reps. Earl Blumenauer (D-OR) and Andy Harris (R-MD) sponsored the House version of the research legislation, which is substantively identical to a Senate bill from Sens. Dianne Feinstein (D-CA), Brian Schatz (D-HI) and Chuck Grassley (R-IA) that previously cleared that chamber.
“Thank you to Representatives Blumenauer, Harris, Griffith, Joyce, Mace, and Perlmutter, Delegate Norton, and Senators Feinstein, Grassley, Schatz, Durbin, Klobuchar, Tillis, Kaine, Ernst, Tester, and Murkowski for their leadership,” the president said on Friday.
The four co-chairs of the Congressional Cannabis Caucus—Blumenauer and Reps. Barbara Lee (D-CA), Dave Joyce (R-OH) and Brian Mast (R-FL)—released a joint statement following the president’s signing.
“For decades, the federal government has stood in the way of science and progress—peddling a misguided and discriminatory approach to cannabis. Today marks a monumental step in remedying our federal cannabis laws,” they said. “The Medical Marijuana and Cannabidiol Research Expansion Act will make it easier to study the impacts and potential of cannabis.”
“Research is foundational for the path forward on cannabis policy. Research is essential to better understand the therapeutic benefits of cannabis that have the potential to help millions of Americans struggling with chronic pain, PTSD, multiple sclerosis, anxiety disorders and more.
We celebrate the enactment of this critical and long-overdue legislation, and we know there is much more to do to remedy the ongoing harms of the failed war on drugs. Our caucus will continue working to reimagine the federal government’s approach to cannabis and enact further reforms. In the coming weeks, we are committed to passing subsequent bipartisan, common-sense proposals like the SAFE Banking package, the Veterans Equal Access Act, the PREPARE Act, and the Veterans Medical Marijuana Safe Harbor Act.”
Feinstein said in a tweet that she’s “pleased President Biden has signed into law our legislation to cut red tape around the marijuana research process.”
“After years of negotiation, we’re finally enacting this bill that will result in critical research that could help millions,” she said.
In a press release, Schatz said that “the medical community agrees that we need more research to learn about marijuana’s potential health benefits.”
“Our new law will remove excessive barriers that make it difficult for researchers to study the effectiveness and safety of marijuana, and hopefully, give patients more treatment options,” he said.
Blumenauer and Harris previously championed a separate cannabis research bill that advanced through their chamber in April. Unlike that legislation, however, the newly approved bill notably does not include a provision that scientists had welcomed that would have allowed researchers to access cannabis from state-legal dispensaries to study.
The research legislation further encourages the Food and Drug Administration (FDA) to develop cannabis-derived medicines. One way it proposes doing so is by allowing accredited medical and osteopathic schools, practitioners, research institutions, and manufacturers with a Schedule I registration to cultivate their own cannabis for research purposes.
The Drug Enforcement Administration (DEA) is now mandated to approve applications to be manufacturers of marijuana-derived, FDA-approved drugs under the bill. Manufacturers will also be allowed to import cannabis materials to facilitate research into the plant’s therapeutic potential.
Another section requires the Department of Health and Human Services (HHS) to look at the health benefits and risks of marijuana as well as policies that are inhibiting research into cannabis that’s grown in legal states and provide recommendations on overcoming those barriers.
The bill further states that it “shall not be a violation of the Controlled Substances Act (CSA) for a State-licensed physician to discuss” the risk and benefits of marijuana and cannabis-derived products with patients.
A Congressional Budget Office (CBO) analysis published in July found that the proposal would reduce direct spending by less than $500,000 and would have a “negligible net change in the deficit.”
There are only a few changes in this new bill compared to the original version the Senate passed earlier this year.
For example, the text now says that researchers won’t need to notify or receive a review from DEA if change study protocols, as long as they already have a Schedule I registration. The previous language said broadly that researchers wouldn’t need to reapply for approval. Also, the new version makes more explicit references to cannabis in the text, rather than “drug” generally.
Another revision deals with a section that mandates the attorney general to conduct an annual review of the supply of cannabis that’s available for research purposes. The new bill says DOJ must carry out that review in consultation with HHS, and says that the latter department will need to submit a report to Congress if it determines that the supply is inadequate.
Finally, a section of the original bill concerning the importation of CBD for research purposes was removed from the new measure.
Both the House and Senate passed earlier versions of their separate but similar cannabis research bills in late 2020, but nothing ended up getting to then-President Donald Trump’s desk by the end of the last Congress.
Congressional researchers separately released a report in March that details the challenges posed by ongoing federal prohibition and the options that lawmakers have available to address them.
DEA has taken steps in recent years to approve new cultivators of marijuana to be used in studies, and the National Institute on Drug Abuse (NIDA) recently published a solicitation for applications from those authorized growers as it looks for new contractors to supply the agency with cannabis for research purposes.
Meanwhile, large-scale infrastructure legislation that was signed by Biden last year contains provisions aimed at allowing researchers to study the actual marijuana that consumers are purchasing from state-legal businesses instead of having to use only government-grown cannabis.
Sen. John Hickenlooper (D-CO) sought an update this week on the status of a federal report into research barriers that are inhibiting the development of a standardized test for marijuana impairment on the roads, as required under that infrastructure legislation.
NIDA Director Nora Volkow told Marijuana Moment last year that scientists have been unnecessarily limited in the source of cannabis they’re permitted to study—and it makes sense to enact a policy change that expands their access to products available in state-legal markets.
Also, last month, congressional lawmakers held a hearing to discuss federal marijuana legalization and state cannabis developments, hearing testimony from a panel of broadly pro-reform advocates.
The chairman of the subcommittee that held that hearing also said on Tuesday that he will soon be introducing a bill aimed at protecting federal workers from being denied security clearances over marijuana.
Sen. Jacky Rosen (D-NV) filed a bill last month that would allow state-legal marijuana businesses to access certain federal Small Business Administration (SBA) loans and services that are available to companies in any other industry.
.0016 are up on the ASK!!
MM put 10M up, they still don't want it to run yet.
5 Million ASK slapped .0015 !!
Could we finally start moving? LOL
Oregon governor takes lead with marijuana pardons.
It's time other states act as well.
The disconnect between Americans' acceptance of marijuana and how outdated laws are enforced begs for action.
Carli Pierson
USA TODAY
Oregon Gov. Kate Brown recently announced that she will pardon 47,144 people who were convicted for possessing small amounts of marijuana.
Brown is the first governor in the country to take such an action, although President Joe Biden announced in October that he was pardoning people with federal convictions of simple marijuana possession. The president's move could help more than 6,500 people.
In a country with permissive cannabis laws in many states – and with strong support among the American public for legalization – no one in the USA should have their lives ruined for possessing marijuana.
Brown clearly realized this and is ensuring that Oregonians with convictions for possessing an ounce or less of marijuana aren't held back any longer financially or otherwise.
Other states should follow suit.
Oregon Gov. Kate Brown
The law and its application
Today, 37 states, four U.S. territories and Washington, D.C., allow for medical marijuana use. Recreational possession and use is allowed for adults in19 states.
America is ready for marijuana reform. Biden's pardon announcement proves it.
Despite such widespread acceptance of marijuana use, nearly half of drug busts still involve cannabis.
And even though Black and white people use marijuana at about the same rate, Black Americans are significantly more likely to be arrested than their white counterparts, even in states where marijuana is legal. Similarly, Black mothers are more likely than white mothers to have their children taken away from them for marijuana use.
Cannabis activist and entrepreneur Evelyn LaChapelle, right, talks to an employee at a dispensary displaying her line of cannabis accessories in Oakland, Calif., on Oct. 7, 2022.
The disconnect between Americans' acceptance of marijuana and how outdated laws are enforced begs for action.
Time for change:Federal ban on marijuana use causes more harm than good
The consequences of conviction
A conviction for possessing even a small amount of cannabis can present a significant hurdle to employment, access to housing and education.
Economists say enforcement of cannabis laws also is expensive. A 2018 CATO Institute report found that state and federal governments could redirect significant amounts of money to meet other needs if criminalization of marijuana use ended. Budgets also might swell with new tax dollars collected from legal marijuana sales.
End war on drugs:He's serving 40 years in prison, while legal marijuana makes others rich
When Brown announced her pardon for Oregonians convicted for possessing small amounts of marijuana, she also announced that about $14 million in fines will be forgiven. That's money families struggling with soaring food and energy prices can keep.
US senator wants marijuana businesses to access SBA loans
By MJBizDaily Staff
November 22, 2022 - Updated November 22, 2022
In a move that could help capital-starved social equity businesses compete with deep-pocketed investors, a U.S. senator introduced a bill that would enable marijuana entrepreneurs to receive Small Business Administration (SBA) loans.
If approved by Congress and signed into law by President Joe Biden, the Fair Access for Cannabis Small Business Act introduced by Sen. Jacky Rosen, D-Nevada, would open SBA programs to “legally operating cannabis businesses” who are currently prohibited from such federal assistance.
That second-class status was keenly felt during the worst months of the COVID-19 pandemic in 2020, when emergency payments and forgiven loans from the Paycheck Protection Program extended to most U.S. owners were not available to plant-touching firms.
That disparity hurt small companies more than well-capitalized multistate operators.
“The unfair barriers to basic federal support and resources have hurt our state’s legally-operating cannabis small businesses,” Rosen said in a statement announcing her legislation.
Rosen’s bill is one of several up for consideration in the lame-duck session of Congress that ends in December.
While most industry attention is on the SAFE Banking Act, which would prohibit federal banking regulators from punishing financial institutions that offer banking services to legal cannabis operators, Congress last week sent a marijuana research bill to Biden’s desk.
Though some states offer social equity businesses assistance in the way of startup capital or built-out facilities, access to SBA loans would be a major milestone and significant boost to diversifying the marijuana industry, advocates said.
“Senator Rosen’s landmark legislation would help advance equity and innovation in the cannabis industry by leveling the playing field for independent cannabis operators,” Khadijah Tribble, CEO of the U.S. Cannabis Council and a senior vice president at Curaleaf Holdings, said in a statement.
“If paired with the SAFE Banking Act, The Fair Access for Cannabis Small Businesses Act would create a regulatory framework that would ensure a vibrant startup scene and a diversity of players.”
TCA was a PVSP lender convicted of Fraud
These guys were crooks and Feds convicted them of Fraud, and the loan was dismissed in court. The period of a potential appeal etc expired which was totally expected.
Senator Files Bill To Provide Marijuana Businesses With Federal Small Business Loans And Assistance That Other Industries Get
A U.S. senator has filed a new bill that would allow state-legal marijuana businesses to access certain federal Small Business Administration (SBA) loans and services that are available to companies in any other industry.
Sen. Jacky Rosen (D-NV) introduced the legislation on Thursday, amid a week of significant congressional activity on cannabis reform issues.
The senator’s proposal would prevent SBA from denying a series of loans and other services—including disaster relief, microloans and technical assistance—to businesses solely because they are involved in state-legal cannabis markets.
“The unfair barriers to basic federal support and resources have hurt our state’s legally-operating cannabis small businesses,” Rosen told Marijuana Moment. “This legislation will level the playing field so that cannabis small businesses—including those owned by people of color, women, and veterans—have access to the same federal resources and loans that other legal businesses are entitled to.”
The “Fair Access for Cannabis Small Businesses Act” contains similar provisions to a House bill filed last year by Rep. Nydia Velázquez (D-NY), though that legislation also contained broader language to remove marijuana from the Controlled Substances Act (CSA).
The new bill does’t have those federal legalization provisions, but it would amend the Small Business Act to add language to various sections stipulating that loans and services can’t be denied “solely because the borrower is a cannabis-related legitimate business or service provider.”
Rosen’s legislation also includes a couple additional amendments to the Small Business Act that were not included in Velázquez’s bill, such as ensuring that cannabis businesses can access “assistance from resource partners” and service providers like small business development centers, women’s business centers and veteran business outreach centers.
.A section on SBA technical assistance would also be uniquely amended under Rosen’s bill to support the cannabis industry.
“For Black and brown communities that have been ravaged by the war on drugs for decades, there is a light at the end of the tunnel as the end of cannabis prohibition comes near,” U.S. Cannabis Council (USCC) CEO Khadijah Tribble said in a press release on Friday. “But without access to capital through financing tools like SBA loans, most Black and brown cannabis entrepreneurs won’t get the chance to profit from an industry that was once used to stigmatize them—even in states where the plant has been legalized.”
Congress Is Shaking It Up On Cannabis Reform
Congress Is Shaking It Up On Cannabis Reform, Some Wish They'd Started Sooner But Better Late Than Never
As the lame-duck Congress scurries to get its ducks in order before they get pushed out of the nest, lawmakers are doing their best for cannabis and psychedelics reform.
Here’s what happened in the past several days.
Let’s start with the fact that President Joe Biden intends to sign the bipartisan marijuana research bill that Congress passed on Wednesday. This marks the first time ever that a standalone piece of cannabis reform legislation will be signed by a US President.
The bill will facilitate research on cannabis and its potential health benefits by streamlining the application process for scientific marijuana studies and removing existing barriers for researchers who have stalled for decades.
“The Senate’s unanimous passage of this legislation represents a significant change in posture towards much needed and meaningful cannabis reform," said said Khadijah Tribble, CEO of the US Cannabis Council and a senior VP at Curaleaf Holdings (OTC: CURLF).
Then on Thursday, Sen. Jacky Rosen (D-NV) filed a new bill that would allow state-legal marijuana businesses to access certain federal Small Business Administration (SBA) loans and services. The cannabis industry is on the outs with the banking system due to weed's classification as a Schedule I drug.
Also on Thursday, Sens. Chris Van Hollen (D-MD) and Rob Portman (R-Oh) and Reps. Danny Davis (D-IL) and David Schweikert (R-AZ) filed legislation to repeal the onerous lifetime ban on receiving the American Opportunity Tax Credit (AOTC) for students with felony drug convictions.
“This backwards requirement makes it more difficult to ensure successful reentry for those who have served their time by limiting their ability to advance their education and pursue a career,” said the lawmakers in their filing.
Earlier in the week, Maryland Rep. Jamie Raskin (D) laid out a bill (not yet filed) in the House Oversight subcommittee that will deal with employment issues facing nearly 3 million federal workers who regularly get disqualified from jobs for admitting they’ve consumed cannabis at some point.
Marijuana industry hopeful for federal reform during lame-duck Congress
author Chris Roberts, Reporter
November 17, 2022
SHARE
Join MJBiz CEO Chris Walsh when he delivers his highly anticipated ‘State of the Industry’ Keynote at MJBizCon (Nov. 15-18) to gain a better understanding of where legal cannabis is headed post-midterm elections and in 2023 and beyond.
Marijuana industry entrepreneurs and investors, exhausted and eager to catch a break after a difficult year of declining sales, tumbling prices, and vanishing capital, believe relief is on its way from an unlikely quarter: the U.S. Congress.
Headed into the brief “lame duck” session of Congress – the period between this past Monday, when Congress reconvened after the midterms, and Jan. 3, when the new Congress is seated – there’s hope among industry insiders that this slim window offers the best opportunity during President Joe Biden’s first term to pass substantive federal marijuana reform.
Lobbyists and Washington DC insiders agree the lame-duck session represents the best opportunity.
The problem: The chances are slim, and the votes might not be there in the Senate.
Roughly 50 marijuana-related bills are circulating in Congress – including Democratic and Republican visions of federal legalization plus bills to lift restrictions on cannabis research and allow MJ to be shipped via the U.S. mail.
But the legislation considered to have the best chance of passage is some version of the SAFE Banking Act, which would forbid federal banking regulators from punishing financial institutions that do business with “legitimate cannabis-related” firms.
Major industry lobbies such as the U.S. Cannabis Council (USCC) – which represents multistate operators and spent $220,000 wheedling lawmakers during the first quarter of 2022 – “believe the Senate has the votes to turn the SAFE Banking Act into law during the lame-duck session,” said Khadijah Tribble, USCC’s CEO and a senior vice president at Curaleaf Holdings, a Massachusetts-based MSO.
Mike Tyson and Ric Flair tag-team the cannabis space and wait
Lot of BIG Names getting positioned for Cannabis Explosion that is Coming!!
Mike Tyson and Ric Flair tag-team the cannabis space and wait, is that Evander Holyfield?
Former heavyweight boxing champion Mike Tyson credits cannabis with turning his life around -- mentally and financially
BY ADAM TSCHORN, ERIK HIMMELSBACH-WEINSTEIN, MARK E. POTTS, CODY LONG, STEVE SALDIVAR
NOV. 17, 2022 8 AM PT
In the years since the sun set on his legendary boxing career, Mike Tyson has been many things. You might have seen him play a fictionalized version of himself in “The Hangover.” You might have downloaded his podcast “Hotboxin’ with Mike Tyson” and heard him hold court with celebrities from Snoop Dogg to William Shatner.
And, even if you’re not a cannabis consumer, you almost definitely heard about his Orange County, Calif., based weed brand Tyson 2.0 when, earlier this year, it released a bitten-ear-shaped THC-infused edible that paid homage to the infamous 1997 “Bite Fight” in which he bit Evander Holyfield’s ear.
How that product came to be, how marijuana has improved his quality of life and where the cannabis entrepreneur hopes to take the brand (hint: it involves celebrities — and Standard Oil) — were among the many herb-related topics touched on when he, flamboyant recently retired wrestler Ric Flair (the face of a just-launched Tyson 2.0 sub-brand called Ric Flair Drip) and company co-founder Chad Bronstein sat down with the “Green Room” team in mid-October in the Santa Monica studio where Tyson was recording episodes of his podcast.
22M on BID Conversion
Volume picking up. 30M in first 5 minutes trading.
We just have to wait until they can get this Debt converted. Pick up some cheapies when you can is the play for next few weeks.
Save Banking Act up by End of Year!!!!
Cannabis Legislation passed Unanimous both Houses !!
What’s next: The legislation also sets up ongoing discussion on the Safe Banking Act, a bipartisan bill that Senate Majority Leader Chuck Schumer has said he wants to pass before this Congress ends.
Passage of the medical research bill by unanimous consent signals that perceptions about marijuana are changing. While expanded research is arguably the most conservative action Congress could take on marijuana, it is something that would have been unthinkable a decade ago. The bill came close to passing in September, but was held up by Sen. John Cornyn (R-Texas). Cornyn lifted the hold earlier this week.
“After working on the issue of cannabis reform for decades, finally the dam is starting to break,” Blumenauer told POLITICO in a statement. “At a time when more than 155 million Americans reside where adult-use of cannabis is legal at the state or local level and there are four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able to fully study the impacts of cannabis use.
What’s next: The legislation also sets up ongoing discussion on the Safe Banking Act, a bipartisan bill that Senate Majority Leader Chuck Schumer has said he wants to pass before this Congress ends.
Congress sends first weed bill to Biden
Passage of the legislation signaled a new era in federal cannabis policy: It’s the first standalone marijuana-related bill approved by both chambers of Congress.
The Senate passed a bill designed to expand medical marijuana research on Wednesday by unanimous consent.
Passage of the legislation, which is sponsored by Sen. Dianne Feinstein (D-Calif.) and Rep. Earl Blumenauer (D-Ore.) in their respective chambers, signaled a new era in federal cannabis policy: It’s the first standalone marijuana-related bill approved by both chambers of Congress. The House passed the bill in July, also by unanimous consent.
Because cannabis is a Schedule I substance, however, it is very difficult to research. Scientists need to get approval from multiple agencies to conduct studies, which can sometimes take years. And until recently, they were only allowed to use marijuana grown by the University of Mississippi — which more closely resembled the weed available on the street in the 1970s, rather than modern-day dispensary products.
Biden on the campaign trail said that marijuana needs to be easier to study, and last month issued an executive order instructing the Department of Health and Human Services to begin a review process of available research on marijuana and issue a recommendation to the Department of Justice on reclassifying or declassifying marijuana from the CSA.
Passage of the medical research bill by unanimous consent signals that perceptions about marijuana are changing. While expanded research is arguably the most conservative action Congress could take on marijuana, it is something that would have been unthinkable a decade ago. The bill came close to passing in September, but was held up by Sen. John Cornyn (R-Texas). Cornyn lifted the hold earlier this week.
“After working on the issue of cannabis reform for decades, finally the dam is starting to break,” Blumenauer told POLITICO in a statement. “At a time when more than 155 million Americans reside where adult-use of cannabis is legal at the state or local level and there are four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able to fully study the impacts of cannabis use.”
What’s next: The legislation also sets up ongoing discussion on the Safe Banking Act, a bipartisan bill that Senate Majority Leader Chuck Schumer has said he wants to pass before this Congress ends.
Senate passed H.R. 8454, to President for Signature
The Senate passed H.R. 8454 (Medical Marijuana and Cannabidiol Research Expansion Act)
Senate Sends Marijuana Research Bill To Biden’s Desk, With Schumer Saying He’s Having ‘Productive Talks’ On Broader Reform
Just weeks after President Joe Biden issued a mass marijuana pardon and directed a review of the drug’s scheduling status, the U.S. Senate approved House-passed bipartisan cannabis research bill on Wednesday. It marks the first time a standalone piece of marijuana reform legislation has ever been sent to the president’s desk.
Just before the vote, Senate Majority Leader Chuck Schumer (D-NY) said on the floor that he is continuing to have “productive talks” about a broader package of cannabis reforms he hopes to pass before the end of the lame duck session.
In the meantime, while numerous marijuana measures have been filed and advanced in each chamber in recent sessions, reform has consistently stalled before reaching the president. But now, the “Medical Marijuana and Cannabidiol Research Expansion Act” is just one signature away from historic enactment.
Just weeks after President Joe Biden issued a mass marijuana pardon and directed a review of the drug’s scheduling status, the U.S. Senate approved House-passed bipartisan cannabis research bill on Wednesday. It marks the first time a standalone piece of marijuana reform legislation has ever been sent to the president’s desk.
Just before the vote, Senate Majority Leader Chuck Schumer (D-NY) said on the floor that he is continuing to have “productive talks” about a broader package of cannabis reforms he hopes to pass before the end of the lame duck session.
In the meantime, while numerous marijuana measures have been filed and advanced in each chamber in recent sessions, reform has consistently stalled before reaching the president. But now, the “Medical Marijuana and Cannabidiol Research Expansion Act” is just one signature away from historic enactment.
The bill was filed in July and quickly moved through the House before being taken up by the Senate, which approved the legislation under unanimous consent.
The latest vote came one day after a House subcommittee held a hearing on cannabis legalization.
Senate leadership had planned to pass the measure in late September, but Sen. John Cornyn (R-TX) objected to the expedited process despite his stated support for marijuana research—delaying the action while the senators left for a multi-week recess around the midterm elections.
That hold was pulled on Tuesday, clearing its path to the Senate floor.
The bill “would eliminate the red tape that hinders cannabis research, opening the door for new innovative treatments derived from cannabis,” Schumer said ahead of the vote. “If you’re one of the millions of Americans who deals with conditions like Parkinson’s or epilepsy or post-traumatic stress, or any number of other conditions, cannabis might hold promising new options for managing these diseases.”
“We need to do the research first,” he said. “And the federal government, sadly, has been woefully behind the times on this front. This bill will help fix that.”
The majority leader then turned to the issue of further reforms.
“I hope after passing this bill the Senate can make progress on other cannabis legislation, too,” he said. “I’m still holding productive talks with Democratic and Republican colleagues in the House and the Senate on moving additional bipartisan cannabis legislation in the lame duck.”
“We’re going to try very, very hard to get it done,” Schumer said. “It’s not easy, but we’re making good progress. I thank my colleagues for the the excellent work on this [research] bill and hope it portends more good cannabis legislation to come.”
I have to look it up, I keep all the tapes
I will look them up since the announcement, but on average it has been about 4M shares a day and at one time we had a friendly agreement with Mammoth Corp Brad Hare to limit conversions to no more than 4M shares or like 5% of the daily volume,or something like that.
2nd group of 4M conversion done.
That was 9M today. If we keep this up, we will be converting 50M a week, and 3 weeks we will be done with this conversion business.
Got the 5M share conversion done
That was early for those, but even at 5m a day it will be done by year end at the latest, another 6 weeks at most, much sooner if we get a few more 30M Buys.
NO ONE IS SELLING, every now and the a few million share Schwab guys jump off the bridge, but 99.99% of investor are holding for the big money, and it will come, just a matter of time, as the market and sector will improve in 2023 & 2024.
Now is accumulation time, buy em and put them away.
LOL, 30 MILLION on BID .0013!!
Need a few more, LOL, LOL
Sundial Growers announces $100M Share Buyback
Management stepping up to address shareholders concerns regarding the low price of the company shares.
Artizen are you listening?
Markets don't know anything about PVSP, LOL
Take a break and stop with the whining, the entire Cannabis sector along with every other sector is down significantly from recent highs a year or more ago.
It is called a BEAR market, and it is just like every other BEAR market, speculation gets rung out of the stock prices and when the economic conditions become favorable once again, the next BULL market will begin and stocks will take off for a few years, and the cycle repeats itself over and over again.
We are much closer to a Bottom than we are to a Top, that you can be sure of. No one know the exact bottom, but it is very close IMO.
This the Accumulation Phase for smart investors. Traders on the other hand are buried in their fox holes licking their wounds and no longer playing the game.
2023 and 2024 are going to look very different, mark my words.
All 14 Cannabis Companies UP GREEN!!
PVSP is the only Cannabis company in my Cannabis world that is not up, and it is one of the best companies fundamentally, go figure, LOL
Dems are going for Cannabis decriminalization by YEAR END!!
Pennsylvania Marijuana Legalization Prospects Increase
Another State to Legalize Cannabis, soon the FEDs will have to decriminalize it, if not by year end, then next year at the latest.
Pennsylvania Marijuana Legalization Prospects Increase As Democrats Claim Majority In House, With Incoming Pro-Reform Governor
Pennsylvania Democrats say that they’ve won enough seats to take control of the House after Tuesday’s election—a development that could have major implications for marijuana reform in the state, where the newly elected governor backs legalization.
While votes are technically still being counted for two more House seats—with Democrats currently just one shy of a 102-member majority in the chamber—the party is declaring victory nonetheless. Meanwhile, Republicans will keep control of the Senate, with a 28-22 majority, the GOP says—but advocates are cautiously optimistic that the political shift in the House significantly improves the odds of enacting cannabis reform.
https://www.marijuanamoment.net/pennsylvania-marijuana-legalization-prospects-increase-as-democrats-claim-majority-in-house-with-incoming-pro-reform-governor/
Minnesota Senate flips to Dem, Legal Mj will pass now.
MINNEAPOLIS -- Former governor Jesse Ventura says that Gov. Tim Walz, fresh off Tuesday's vote that will send the DFL incumbent to a second term, told him that legalizing marijuana will be "one of the first" things that gets passed by the incoming state legislature.
The comments were made on a podcast with his son, Tyrel Ventura. The former governor said that Walz also invited him to the ceremony where he signs the bill into law.
A spokesperson with Walz confirmed Jesse Ventura's comments, adding that they "may work together to get something done."
This comes after voters flipped the Minnesota Senate, which had been in the Republican Party's control going into this week's midterms.
The Minnesota House passed a bill last May to allow adult-use recreational cannabis in the state. It also had provisions that expunged low-level cannabis convictions, including for possessing small amounts. But the policy failed in the Senate, where Republicans rejected it -- though some expressed openness to further decriminalization.
WOW Future Blast Off Dow + 850 pts
Inflation numbers lower than expected, signaling Inflation is Cooling and the Fed may decide to take a break on raising interest rates.
Will not be long now
Just when you least expect it, always happens, LOL